Two-year intermittent exposure of a multiwalled carbon nanotube by intratracheal instillation induces lung tumors and pleural mesotheliomas in F344 rats. 2022

Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shinjuku, Tokyo, 169-0073, Japan. motoki_hojo@member.metro.tokyo.jp.

A mounting number of studies have been documenting the carcinogenic potential of multiwalled carbon nanotubes (MWCNTs); however, only a few studies have evaluated the pulmonary carcinogenicity of MWCNTs in vivo. A 2-year inhalation study demonstrated that MWNT-7, a widely used MWCNT, was a pulmonary carcinogen in rats. In another 2-year study, rats administered MWNT-7 by intratracheal instillation at the beginning of the experimental period developed pleural mesotheliomas but not lung tumors. To obtain data more comparable with rats exposed to MWNT-7 by inhalation, we administered MWNT-7 to F344 rats by intratracheal instillation once every 4-weeks over the course of 2 years at 0, 0.125, and 0.5 mg/kg body weight, allowing lung burdens of MWNT-7 to increase over the entire experimental period, similar to the inhalation study. Absolute and relative lung weights were significantly elevated in both MWNT-7-treated groups. Dose- and time-dependent toxic effects in the lung and pleura, such as inflammatory, fibrotic, and hyperplastic lesions, were found in both treated groups. The incidences of lung carcinomas, lung adenomas, and pleural mesotheliomas were significantly increased in the high-dose group compared with the control group. The pleural mesotheliomas developed mainly at the mediastinum. No MWNT-7-related neoplastic lesions were noted in the other organs. Cytological and biochemical parameters of the bronchoalveolar lavage fluid (BALF) were elevated in both treated groups. The lung burden of MWNT-7 was dose- and time-dependent, and at the terminal necropsy, the average value was 0.9 and 3.6 mg/lung in the low-dose and high-dose groups, respectively. The number of fibers in the pleural cavity was also dose- and time-dependent. Repeated administration of MWNT-7 by intratracheal instillation over the 2 years indicates that MWNT-7 is carcinogenic to both the lung and pleura of rats, which differs from the results of the 2 carcinogenicity tests by inhalation or intratracheal instillation.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D000086002 Mesothelioma, Malignant A type of mesothelioma with a tendency to metastasize. Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240. Malignant Mesothelioma,Malignant Pleural Mesothelioma,Mesothelioma, Malignant Pleural,Malignant Mesotheliomas,Malignant Pleural Mesotheliomas,Mesotheliomas, Malignant,Mesotheliomas, Malignant Pleural,Pleural Mesothelioma, Malignant,Pleural Mesotheliomas, Malignant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D037742 Nanotubes, Carbon Nanometer-sized tubes composed mainly of CARBON. Such nanotubes are used as probes for high-resolution structural and chemical imaging of biomolecules with ATOMIC FORCE MICROSCOPY. Buckytubes,Carbon Nanotubes,Nanoribbons,Buckytube,Carbon Nanotube,Nanoribbon,Nanotube, Carbon

Related Publications

Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
August 2019, Cancer science,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
March 2015, Chemical research in toxicology,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
March 2012, Environmental toxicology,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
December 2012, Journal of toxicologic pathology,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
June 2008, Inhalation toxicology,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
April 2019, Journal of visualized experiments : JoVE,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
January 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
November 2008, Toxicology,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
June 2008, Toxicologic pathology,
Motoki Hojo, and Ai Maeno, and Yoshimitsu Sakamoto, and Aya Ohnuki, and Yukie Tada, and Yukio Yamamoto, and Kiyomi Ikushima, and Ryota Inaba, and Jin Suzuki, and Yuhji Taquahashi, and Satoshi Yokota, and Norihiro Kobayashi, and Makoto Ohnishi, and Yuko Goto, and Takamasa Numano, and Hiroyuki Tsuda, and David B Alexander, and Jun Kanno, and Akihiko Hirose, and Akiko Inomata, and Dai Nakae
March 2009, Journal of toxicologic pathology,
Copied contents to your clipboard!